Status:
COMPLETED
Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section
Lead Sponsor:
University of Parma
Conditions:
Cesarean Section
Anesthesia,Spinal
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The aim of this study is to assess the efficacy of atropine in preventing nausea and vomiting after spinal anesthesia with local anesthetic and morphine for elective Caesarean section. Patients enrol...
Detailed Description
Intrathecal (IT) morphine grants effective, durable and safe analgesia after Caesarean section. The most common adverse effects after IT morphine are widespread pruritus and postoperative nausea and v...
Eligibility Criteria
Inclusion
- Patients scheduled for elective Cesarean section at up to 42 weeks and 2 days
- Patients in ASA Physical Status Class I or II
- Informed written consent to participation
- No known gestosis
Exclusion
- Any known fetal pathology
- Indication to general anesthesia
- Known allergy to any of the study drugs
- Baseline bradycardia or any cardiovascular disease
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT00921102
Start Date
May 1 2007
End Date
May 1 2008
Last Update
June 16 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Messina
Messina, ME, Italy, 98122
2
University and Hospital of Parma (Azienda Ospedaliero-Universitaria di Parma)
Parma, PR, Italy, 43126